Shiyao Pei

1.2k total citations
18 papers, 756 citations indexed

About

Shiyao Pei is a scholar working on Cell Biology, Molecular Biology and Oncology. According to data from OpenAlex, Shiyao Pei has authored 18 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cell Biology, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Shiyao Pei's work include melanin and skin pigmentation (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Skin Protection and Aging (4 papers). Shiyao Pei is often cited by papers focused on melanin and skin pigmentation (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Skin Protection and Aging (4 papers). Shiyao Pei collaborates with scholars based in China, Canada and United States. Shiyao Pei's co-authors include Mingzhu Yin, Xiang Chen, Rui Hu, Chaofei Han, Qinghai Zeng, Jing Chen, Jinhua Huang, Jianyun Lu, Liyang Kang and Yufang Ding and has published in prestigious journals such as Nature Communications, Clinical Cancer Research and Journal of Investigative Dermatology.

In The Last Decade

Shiyao Pei

17 papers receiving 744 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Shiyao Pei 273 192 146 143 120 18 756
Avninder Singh 188 0.7× 83 0.4× 63 0.4× 120 0.8× 51 0.4× 53 821
Seyeon Bae 232 0.8× 46 0.2× 85 0.6× 34 0.2× 47 0.4× 19 853
Chunli Zhou 291 1.1× 41 0.2× 47 0.3× 25 0.2× 59 0.5× 36 614
Mélanie Pucelle 279 1.0× 49 0.3× 105 0.7× 24 0.2× 95 0.8× 16 726
Yujun Chen 196 0.7× 100 0.5× 38 0.3× 57 0.4× 76 0.6× 67 706
Ben Wang 138 0.5× 176 0.9× 21 0.1× 471 3.3× 44 0.4× 59 766
Tianshu Yang 447 1.6× 24 0.1× 65 0.4× 22 0.2× 194 1.6× 38 939
Sven Stengel 433 1.6× 46 0.2× 26 0.2× 56 0.4× 54 0.5× 30 834
Yu‐Hsin Tseng 245 0.9× 42 0.2× 28 0.2× 28 0.2× 104 0.9× 32 634
Yong Beom Choe 130 0.5× 167 0.9× 48 0.3× 677 4.7× 18 0.1× 76 1.2k

Countries citing papers authored by Shiyao Pei

Since Specialization
Citations

This map shows the geographic impact of Shiyao Pei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiyao Pei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiyao Pei more than expected).

Fields of papers citing papers by Shiyao Pei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiyao Pei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiyao Pei. The network helps show where Shiyao Pei may publish in the future.

Co-authorship network of co-authors of Shiyao Pei

This figure shows the co-authorship network connecting the top 25 collaborators of Shiyao Pei. A scholar is included among the top collaborators of Shiyao Pei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiyao Pei. Shiyao Pei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zhao, Shuang, Shiyao Pei, Teng Liu, et al.. (2025). The Dynamically Evolving Cell States and Ecosystem from Benign Nevi to Melanoma. Clinical Cancer Research. 31(12). 2478–2494.
2.
Li, Xin, Rui Hu, Liang Dong, et al.. (2025). BET inhibitor in combination with BCG vaccine enhances antitumor efficacy and orchestrates T cell reprogramming for melanoma. Cell Reports Medicine. 6(3). 101995–101995. 1 indexed citations
3.
Dong, Liang, Xin Li, Shiyao Pei, et al.. (2024). SPP1+ TAM Regulates the Metastatic Colonization of CXCR4+ Metastasis‐Associated Tumor Cells by Remodeling the Lymph Node Microenvironment. Advanced Science. 11(44). e2400524–e2400524. 18 indexed citations
4.
Jin, Liping, Liang Dong, Shiyao Pei, et al.. (2024). A BET inhibitor, NHWD-870, can downregulate dendritic cells maturation via the IRF7-mediated signaling pathway to ameliorate imiquimod-induced psoriasis-like murine skin inflammation. European Journal of Pharmacology. 968. 176382–176382. 6 indexed citations
5.
Huang, Lingjuan, Xianggui Wang, Shiyao Pei, et al.. (2023). Single-Cell Profiling Reveals Sustained Immune Infiltration, Surveillance, and Tumor Heterogeneity in Infiltrative Basal Cell Carcinoma. Journal of Investigative Dermatology. 143(11). 2283–2294.e17. 7 indexed citations
6.
Zhao, Shuang, Xiaohui Bian, Lixia Lu, et al.. (2022). Signatures of EMT, immunosuppression, and inflammation in primary and recurrent human cutaneous squamous cell carcinoma at single-cell resolution. Theranostics. 12(17). 7532–7549. 39 indexed citations
7.
Pei, Shiyao, Qin Ren, Liang Yu, et al.. (2021). Evaluation of vertical transmission of SARS-CoV-2 in utero: Nine pregnant women and their newborns. Placenta. 111. 91–96. 9 indexed citations
8.
Pei, Shiyao, Xi Yuan, Yubin Xie, et al.. (2021). Convalescent plasma to treat COVID-19: clinical experience and efficacy. Aging. 13(6). 7758–7766. 4 indexed citations
9.
Yin, Mingzhu, Ying Guo, Rui Hu, et al.. (2020). Potent BRD4 inhibitor suppresses cancer cell-macrophage interaction. Nature Communications. 11(1). 1833–1833. 115 indexed citations
10.
Hu, Rui, Chaofei Han, Shiyao Pei, Mingzhu Yin, & Xiang Chen. (2020). Procalcitonin levels in COVID-19 patients. International Journal of Antimicrobial Agents. 56(2). 106051–106051. 187 indexed citations
11.
Fu, Chuhan, Jing Chen, Jianyun Lu, et al.. (2020). Roles of inflammation factors in melanogenesis (Review). Molecular Medicine Reports. 21(3). 1421–1430. 122 indexed citations
12.
Pei, Shiyao, Jing Chen, Jianyun Lu, et al.. (2019). The Long Noncoding RNA UCA1 Negatively Regulates Melanogenesis in Melanocytes. Journal of Investigative Dermatology. 140(1). 152–163.e5. 30 indexed citations
13.
Jiang, Ling, Jinhua Huang, Jianyun Lu, et al.. (2019). Ganoderma lucidum polysaccharide reduces melanogenesis by inhibiting the paracrine effects of keratinocytes and fibroblasts via IL‐6/STAT3/FGF2 pathway. Journal of Cellular Physiology. 234(12). 22799–22808. 25 indexed citations
14.
Fu, Chuhan, Jing Chen, Jianyun Lu, et al.. (2019). Downregulation of TUG1 promotes melanogenesis and UVB‐induced melanogenesis. Experimental Dermatology. 28(6). 730–733. 14 indexed citations
15.
Lu, Jianyun, Jinwei Wang, Jian Huang, et al.. (2018). Propranolol as a potentially novel treatment of arteriovenous malformations. JAAD Case Reports. 4(4). 355–358. 8 indexed citations
16.
Chen, Jing, Jinhua Huang, Jianyun Lu, et al.. (2018). Functions and regulatory mechanisms of metastasis‐associated lung adenocarcinoma transcript 1. Journal of Cellular Physiology. 234(1). 134–151. 53 indexed citations
17.
Pei, Shiyao, Jinhua Huang, Jing Chen, et al.. (2018). UVB‐inhibited H19 activates melanogenesis by paracrine effects. Experimental Dermatology. 27(10). 1120–1125. 14 indexed citations
18.
Huang, Jinhua, Shiyao Pei, Yujie Ouyang, et al.. (2018). Ganoderma lucidum polysaccharide inhibits UVB‐induced melanogenesis by antagonizing cAMP/PKA and ROS/MAPK signaling pathways. Journal of Cellular Physiology. 234(5). 7330–7340. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026